Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

Novo Nordisk (NVO) is not concerned by the ongoing US trade war and the 25% tariff set to go into effect for pharmaceutical ...

Still, Novo is steadfast in its goal to eventually become a leader in the space, the company’s EVP of rare disease, Ludovic ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1, ...

Novo Nordisk (NVO) is not concerned by the ongoing ... with a $2.5 billion API production site, and is building out the next step in the supply chain — a $4.1 billion fill-and-finish factory ...

Novo Nordisk's (NYSE: NVO ... The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month ...

Novo Nordisk (NYSE: NVO) shareholders know all ... The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community.

If you want to address civilization and society's issues, then you have to do it with the city," Urban Partners' co-CEO Claus ...